|
1
|
Shichiri M, Ishimaru S, Ota T, Nishikawa
T, Isogai T and Hirata Y: Salusins: Newly identified bioactive
peptides with hemodynamic and mitogenic activities. Nat Med.
9:1166–1172. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Suzuki N, Shichiri M, Akashi T, Sato K,
Sakurada M, Hirono Y, Yoshimoto T, Koyama T and Hirata Y: Systemic
distribution of salusin expression in the rat. Hypertens Res.
30:1255–1262. 2007. View Article : Google Scholar
|
|
3
|
Raposeiras-Roubin S, Rosselló X, Oliva B,
Fernández-Friera L, Mendiguren JM, Andrés V, Bueno H, Sanz J,
Martínez de Vega V, Abu-Assi E, et al: Triglycerides and residual
atherosclerotic risk. J Am Coll Cardiol. 77:3031–3041. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qian K, Feng L, Sun Y, Xiong B, Ding Y,
Han P, Chen H, Chen X, Du L and Wang Y: Overexpression of Salusin-α
inhibits vascular intimal hyperplasia in an atherosclerotic rabbit
model. Biomed Res Int. 2018:89739862018. View Article : Google Scholar
|
|
5
|
Niepolski L and Grzegorzewska AE: Salusins
and adropin: New peptides potentially involved in lipid metabolism
and atherosclerosis. Adv Med Sci. 61:282–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grzegorzewska AE, Niepolski L, Sikora J,
Janków M, Jagodziński PP and Sowińska A: Effect of lifestyle
changes and atorvastatin administration on dyslipidemia in
hemodialysis patients: A prospective study. Pol Arch Med Wewn.
124:443–451. 2014.PubMed/NCBI
|
|
7
|
Fang H and Judd RL: Adiponectin regulation
and function. Compr Physiol. 8:1031–1063. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parida S, Siddharth S and Sharma D:
Adiponectin, obesity, and cancer: Clash of the Bigwigs in health
and disease. Int J Mol Sci. 20:25192019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zha D, Wu X and Gao P: Adiponectin and its
receptors in diabetic kidney disease: Molecular mechanisms and
clinical potential. Endocrinology. 158:2022–2034. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee IK, Kim G, Kim DH and Kim BB:
PEG-BHD1028 peptide regulates insulin resistance and fatty acid
β-oxidation, and mitochondrial biogenesis by binding to two
heterogeneous binding sites of adiponectin receptors, AdipoR1 and
AdipoR2. Int J Mol Sci. 22:8842021. View Article : Google Scholar
|
|
11
|
Furukawa K, Hori M, Ouchi N, Kihara S,
Funahashi T, Matsuzawa Y, Miyazaki A, Nakayama H and Horiuchi S:
Adiponectin down-regulates acyl-coenzyme A: Cholesterol
acyltransferase-1 in cultured human monocyte-derived macrophages.
Biochem Biophys Res Commun. 317:831–836. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yanai H and Yoshida H: Beneficial effects
of adiponectin on glucose and lipid metabolism and atherosclerotic
progression: Mechanisms and perspectives. Int J Mol Sci.
20:11902019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ipsen DH, Lykkesfeldt J and Tveden-Nyborg
P: Molecular mechanisms of hepatic lipid accumulation in
non-alcoholic fatty liver disease. Cell Mol Life Sci. 75:3313–3327.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Younossi ZM, Corey KE and Lim JK: AGA
clinical practice update on lifestyle modification using diet and
exercise to achieve weight loss in the management of nonalcoholic
fatty liver disease: Expert review. Gastroenterology. 160:912–918.
2021. View Article : Google Scholar
|
|
15
|
Perakakis N, Stefanakis K and Mantzoros
CS: The role of omics in the pathophysiology, diagnosis and
treatment of non-alcoholic fatty liver disease. Metabolism.
111:1543202020. View Article : Google Scholar :
|
|
16
|
Scherer A and Dufour JF: Treatment of
non-alcoholic fatty liver disease. Dig Dis. 34:27312016. View Article : Google Scholar
|
|
17
|
Alborn WE, Johnson MG, Prince MJ and
Konrad RJ: Definitive N-terminal protein sequence and further
characterization of the novel apolipoprotein A5 in human serum.
Clin Chem. 52:514–517. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng CH, Yang MY, Yang YS, Yu CC and Wang
CJ: Antrodia cinnamomea prevents obesity, dyslipidemia, and the
derived fatty liver via regulating AMPK and SREBP signaling. Am J
Chin Med. 45:67832017. View Article : Google Scholar
|
|
19
|
Tang K, Wang F, Zeng Y, Chen X and Xu X:
Salusin-α attenuates hepatic steatosis and atherosclerosis in high
fat diet-fed low density lipoprotein receptor deficient mice. Eur J
Pharmacol. 830:76862018. View Article : Google Scholar
|
|
20
|
Koh IU, Lim JH, Joe MK, Kim WH, Jung MH,
Yoon JB and Song J: AdipoR2 is transcriptionally regulated by ER
stressinducible ATF3 in HepG2 human hepatocyte cells. FEBS J.
277:2304–2317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Poznyak A, Grechko AV, Poggio P,
Myasoedova VA, Alfieri V and Orekhov AN: The diabetes
mellitus-atherosclerosis connection: The role of lipid and glucose
metabolism and chronic inflammation. Int J Mol Sci. 21:18352020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qian H, Chao X, Williams J, Fulte S, Li T,
Yang L and Ding WX: Autophagy in liver diseases: A review. Mol
Aspects Med. 82:1009732021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong Y, Yu C, Ma N, Xu X, Wu Q, Lu H, Gong
L, Chen J and Ren J: MicroRNA-379-5p regulates free cholesterol
accumulation and relieves diet induced-liver damage in db/db mice
via STAT1/HMGCS1 axis. Mol Biomed. 3:252022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Q, Zhang Y, Li L, Li J, Li Y, Han L
and Wang M: D-chiro-Inositol facilitates adiponectin biosynthesis
and activates the AMPKα/PPARs pathway to inhibit high-fat
diet-induced obesity and liver lipid deposition. Food Funct.
13:7192–7203. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tomita K, Oike Y, Teratani T, Taguchi T,
Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, et
al: Hepatic AdipoR2 signaling plays a protective role against
progression of nonalcoholic steatohepatitis in mice. Hepatology.
48:458–473. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moreira AS, Cavaco DG, Faria TQ, Alves PM,
Carrondo MJT and Peixoto C: Advances in Lentivirus purification.
Biotechnol J. 16:e20000192021. View Article : Google Scholar
|
|
27
|
Yew CT, Gurumoorthy N, Nordin F, Tye GJ,
Wan Kamarul Zaman WS, Tan JJ and Ng MH: Integrase deficient
lentiviral vector: Prospects for safe clinical applications. PeerJ.
10:e137042022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Prieur X, Coste H and Rodriguez JC: The
human apolipoprotein AV gene is regulated by peroxisome
proliferator-activated receptor-alpha and contains a novel
farnesoid X-activated receptor response element. J Biol Chem.
278:25468–25480. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Joshi A, Upadhyay KK, Vohra A, Shirsath K
and Devkar R: Melatonin induces Nrf2-HO-1 reprogramming and
corrections in hepatic core clock oscillations in non-alcoholic
fatty liver disease. FASEB J. 35:e218032021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim M, Kim M, Yoo HJ, Bang YJ, Lee SH and
Lee JH: Apolipoprotein A5 gene variants are associated with
decreased adiponectin levels and increased arterial stiffness in
subjects with low high-density lipoprotein-cholesterol levels. Clin
Genet. 94:438–444. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wen F, An C, Wu X, Yang Y, Xu J, Liu Y,
Wang C, Nie L, Fang H and Yang Z: MiR-34a regulates mitochondrial
content and fat ectopic deposition induced by resistin through the
AMPK/PPARα pathway in HepG2 cells. Int J Biochem Cell Biol.
94:133–145. 2018. View Article : Google Scholar
|
|
32
|
Yu S, Gao L, Zhang C, Wang Y, Lan H, Chu
Q, Li S and Zheng X: Glycine ameliorates endoplasmic reticulum
stress induced by thapsigargin in porcine oocytes. Front Cell Dev
Biol. 9:7338602021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ozcan U, Yilmaz E, Ozcan L, Furuhashi M,
Vaillancourt E, Smith RO, Görgün CZ and Hotamisligil GS: Chemical
chaperones reduce ER stress and restore glucose homeostasis in a
mouse model of type 2 diabetes. Science. 313:1137–1140. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sinha RA, Rajak S, Singh BK and Yen PM:
Hepatic lipid catabolism via PPARα-lysosomal crosstalk. Int J Mol
Sci. 21:23912020. View Article : Google Scholar
|
|
35
|
Lee YH, Jang HJ, Kim S, Choi SS, Khim KW,
Eom HJ, Hyun J, Shin KJ, Chae YC, Kim H, et al: Hepatic MIR20B
promotes nonalcoholic fatty liver disease by suppressing PPARA.
Elife. 10:e704722021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Brocker CN, Patel DP, Velenosi TJ, Kim D,
Yan T, Yue J, Li G, Krausz KW and Gonzalez FJ: Extrahepatic PPARα
modulates fatty acid oxidation and attenuates fasting-induced
hepatosteatosis in mice. J Lipid Res. 59:2140–2152. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Luo F, Guo Y, Ruan GY, Peng R and Li XP:
Estrogen lowers triglyceride via regulating hepatic APOA5
expression. Lipids Health Dis. 16:722017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ferré P, Phan F and Foufelle F: SREBP-1c
and lipogenesis in the liver: An update1. Biochem J. 478:3723–3739.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li L, Zhang X, Ren H, Huang X, Shen T,
Tang W, Dou L and Li J: miR-23a/b-3p promotes hepatic lipid
accumulation by regulating SREBP-1c and Fas. J Mol Endocrinol.
68:35492021.
|
